Vanderbilt Technologies for Advanced Genomics is a one-stop genomics research resource that offers sample biobanking, genome sequencing, single-cell and spatial multiomic profiling, and other specialized services.

"C. diff is one of those infections that turns a routine hospital stay or a course of antibiotics into something far more serious, and older adults bear the brunt of it."

Study provides a unique resource to guide future research on acute rejection diagnosis, therapeutic response prediction, and risk for chronic rejection.

Patients who qualify for new Alzheimer's disease therapies often wait weeks before receiving a first infusion.

The project will integrate diverse datasets and advanced quantitative approaches to better define the natural history of cardiomyopathy in Duchenne, identify key biomarkers, and support the development of tools to optimize the design and conduct of clinical trials for candidate drugs.

The study followed 756 participants over an 11-year period and examined whether reduced cardiac function could lead to adverse brain health outcomes even in the absence of cardiovascular disease.

The study found that point-of-care ultrasound had a high sensitivity for detecting vitreoretinal pathology, but had only moderate accuracy and a low sensitivity for detecting other ocular pathologies that may require prompt intervention.